AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35398546 — intervention group
Group type: EXPERIMENTAL
Intervention: Air tamponade
Number of subjects: 150
Study 35398546 — intervention group
Group type: COMPARATOR
Intervention: SF6 gas tamponade
Number of subjects: 150
Study 32515067 — intervention group
Group type: EXPERIMENTAL
Intervention: Compassion-focused therapy (CFT) group intervention, 12 sessions, 2 hours each
Number of subjects: 5
Study 32515067 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative feedback from participants
Number of subjects: 5
Study 36443788 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-integrated intermediary care (CIIC) model
Number of subjects: 2788
Study 36443788 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2788
Study 33378717 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimanual or unimanual intensive therapy
Number of subjects: 0
Study 33378717 — intervention group
Group type: COMPARATOR
Intervention: Control group of children with cerebral palsy
Number of subjects: 0
Study 33378717 — intervention group
Group type: COMPARATOR
Intervention: Typically developing children
Number of subjects: 0
Study 32690516 — intervention group
Group type: EXPERIMENTAL
Intervention: HIVST plus standard facility-based counselling and testing from 0 to 12 months
Number of subjects: 1000
Study 32690516 — intervention group
Group type: COMPARATOR
Intervention: Standard facility-based counselling and testing from 0 to 6 months, then crossover to receive the HIVST intervention in months 7-12
Number of subjects: 1000
Study 36137841 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy combined with surgery (NCRT group)
Number of subjects: 451
Study 36137841 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (S group)
Number of subjects: 451
Study 36137841 — intervention group
Group type: EXPERIMENTAL
Intervention: NCRT
Number of subjects: 451
Study 34322621 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) sessions, practice at home, and recorded sound
Number of subjects: 60
Study 34322621 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 36064643 — intervention group
Group type: EXPERIMENTAL
Intervention: OnTrackChile (OTCH) program
Number of subjects: 300
Study 36064643 — intervention group
Group type: COMPARATOR
Intervention: Usual care services
Number of subjects: 300
Study 34874418 — intervention group
Group type: EXPERIMENTAL
Intervention: YEARS rule combined with age-adjusted D-dimer threshold (D-dimer <1000 ng/mL or <500 ng/mL for age <50 years or age in years × 10 for patients ≥50 years)
Number of subjects: 1414
Study 34874418 — intervention group
Group type: COMPARATOR
Intervention: Control group with age-adjusted D-dimer threshold
Number of subjects: 1414
Study 34874418 — intervention group
Group type: EXPERIMENTAL
Intervention: YEARS rule
Number of subjects: 1414
Study 35188677 — intervention group
Group type: EXPERIMENTAL
Intervention: 10Hz rTMS
Number of subjects: 162
Study 35188677 — intervention group
Group type: EXPERIMENTAL
Intervention: iTBS
Number of subjects: 162
Study 34790521 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-L PEG
Number of subjects: 852
Study 34790521 — intervention group
Group type: COMPARATOR
Intervention: 2-L PEG
Number of subjects: 852
Study 33315813 — intervention group
Group type: EXPERIMENTAL
Intervention: Euglycemic group (BG >3.9 to ≤10.0 mmol�L‐1)
Number of subjects: 36
Study 33315813 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperglycemic group (BG >10.0 mmol�L‐1)
Number of subjects: 36
Study 33315813 — intervention group
Group type: COMPARATOR
Intervention: Both groups (comparison)
Number of subjects: 36
Study 36207872 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model based on clinical data and radiomics
Number of subjects: 136
Study 36207872 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics model
Number of subjects: 136
Study 36207872 — intervention group
Group type: COMPARATOR
Intervention: Radscore of EBV positive group
Number of subjects: 136
Study 33941737 — intervention group
Group type: EXPERIMENTAL
Intervention: Legacy intervention (group-based positive parenting interventions)
Number of subjects: 364
Study 33941737 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (mothers who did not participate in the intervention)
Number of subjects: 364
Study 32384509 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbal bath (various temperatures and concentrations)
Number of subjects: 288
Study 32384509 — intervention group
Group type: COMPARATOR
Intervention: Ozone hydrotherapy
Number of subjects: 288
Study 32384509 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic treatment (co‐qingdai capsule, compound glycyrrhizin tablet, AA Skincare jojoba Oil)
Number of subjects: 288
Study 35589616 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirzepatide 10 mg
Number of subjects: 238
Study 35589616 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirzepatide 15 mg
Number of subjects: 238
Study 35589616 — intervention group
Group type: COMPARATOR
Intervention: Tirzepatide 5 mg
Number of subjects: 238
Study 32675334 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational statement on CPOX harms
Number of subjects: 357
Study 32675334 — intervention group
Group type: COMPARATOR
Intervention: Standard CPOX monitoring
Number of subjects: 357
Study 35634931 — intervention group
Group type: EXPERIMENTAL
Intervention: IAT (conventional-dose cytarabine, idarubicin, and thioguanine)
Number of subjects: 356
Study 35634931 — intervention group
Group type: COMPARATOR
Intervention: IdAraC-Ida (intermediate-dose cytarabine and idarubicin)
Number of subjects: 356
Study 35634931 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk classification and measurable residual disease (MRD) assessment
Number of subjects: 356
Study 33986030 — intervention group
Group type: EXPERIMENTAL
Intervention: Eliapixant 750 mg
Number of subjects: 40
Study 33986030 — intervention group
Group type: EXPERIMENTAL
Intervention: Eliapixant ≥50 mg
Number of subjects: 40
Study 33986030 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 33986030 — intervention group
Group type: EXPERIMENTAL
Intervention: Eliapixant (all doses)
Number of subjects: 40
Study 35432581 — intervention group
Group type: EXPERIMENTAL
Intervention: Insomnia patients with more dreams
Number of subjects: 72
Study 32394478 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT) - 2000 shocks, frequency of 3 Hz, maximum total energy flow density 0.25 mJ/mm2, once a week for 4 weeks
Number of subjects: 54
Study 32394478 — intervention group
Group type: COMPARATOR
Intervention: Placebo - shock wave setting without energy transmission
Number of subjects: 54
Study 34839332 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibody-drug conjugates (ADCs)
Number of subjects: 29
Study 34839332 — intervention group
Group type: COMPARATOR
Intervention: Off drug (3-month follow-up)
Number of subjects: 29
Study 34115736 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular Acupressure (AA) on low back pain-related points, 6 weeks duration
Number of subjects: 51
Study 34115736 — intervention group
Group type: COMPARATOR
Intervention: Placebo Auricular Acupressure on points unrelated to low back pain, 6 weeks duration
Number of subjects: 51
Study 32345594 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with cancer
Number of subjects: 105
Study 32345594 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who received surgery
Number of subjects: 105
Study 32345594 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who underwent only radiotherapy
Number of subjects: 105
Study 32345594 — intervention group
Group type: COMPARATOR
Intervention: Nonmetastatic cancer patients
Number of subjects: 105
Study 34490685 — intervention group
Group type: EXPERIMENTAL
Intervention: Phantom limb pain (PLP) group
Number of subjects: 107
Study 34490685 — intervention group
Group type: COMPARATOR
Intervention: Pain-Free peers with LLL
Number of subjects: 107
Study 34490685 — intervention group
Group type: COMPARATOR
Intervention: Controls with intact limbs
Number of subjects: 107
Study 34490685 — intervention group
Group type: EXPERIMENTAL
Intervention: Adults with PLP
Number of subjects: 107
Study 32567518 — intervention group
Group type: EXPERIMENTAL
Intervention: Meetings with a peer mentor
Number of subjects: 0
Study 32567518 — intervention group
Group type: COMPARATOR
Intervention: Organ donation mailings
Number of subjects: 0
Study 32472048 — intervention group
Group type: EXPERIMENTAL
Intervention: Conbercept combined with panretinal photocoagulation (PRP)
Number of subjects: 15
Study 32472048 — intervention group
Group type: COMPARATOR
Intervention: Panretinal photocoagulation (PRP) alone
Number of subjects: 15
Study 34631030 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylnaltrexone (12 mg once daily or 12 mg once every other day; oral methylnaltrexone 150, 300, or 450 mg daily)
Number of subjects: 1263
Study 34631030 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1263
Study 34631030 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylnaltrexone
Number of subjects: 1263
Study 32468267 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial scratching (ES) in the luteal phase of the cycle preceding the embryo transfer cycle (group A)
Number of subjects: 352
Study 32468267 — intervention group
Group type: COMPARATOR
Intervention: No intervention (group B)
Number of subjects: 352
Study 32468267 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial scratching (ES)
Number of subjects: 352
Study 35323856 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with TPC (paclitaxel, cisplatin, capecitabine)
Number of subjects: 238
Study 35323856 — intervention group
Group type: COMPARATOR
Intervention: Induction chemotherapy with PF (cisplatin, fluorouracil)
Number of subjects: 238
Study 35323856 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with TPC
Number of subjects: 238
Study 35725639 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuling-Zexie decoction
Number of subjects: 30
Study 35725639 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 33780091 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved epidural tunneling technique (group I)
Number of subjects: 20
Study 33780091 — intervention group
Group type: COMPARATOR
Intervention: Control tunneling technique (group C)
Number of subjects: 20
Study 32847735 — intervention group
Group type: COMPARATOR
Intervention: Health care provider frequently discussed weight
Number of subjects: 2811
Study 32847735 — intervention group
Group type: COMPARATOR
Intervention: Perceived as normal weight or underweight
Number of subjects: 2811
Study 32847735 — intervention group
Group type: COMPARATOR
Intervention: Never tried to lose at least 10 lbs, ate 0−2 servings of fruits and vegetables daily, or engaged in 0−29 min of physical activity weekly
Number of subjects: 2811
Study 33443017 — intervention group
Group type: EXPERIMENTAL
Intervention: Colon Capsule Endoscopy (CCE)
Number of subjects: 286
Study 33443017 — intervention group
Group type: COMPARATOR
Intervention: CT Colonography (CTC)
Number of subjects: 286
Study 32527192 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified loading strategy (ILS) with prasugrel 60 mg
Number of subjects: 781
Study 32527192 — intervention group
Group type: COMPARATOR
Intervention: Standard loading strategy with clopidogrel 600 mg
Number of subjects: 781
Study 35796097 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetylpyridinium chloride (CPC)
Number of subjects: 54
Study 35796097 — intervention group
Group type: COMPARATOR
Intervention: Four different antiseptic mouthwashes
Number of subjects: 54
Study 35796097 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 33906086 — intervention group
Group type: EXPERIMENTAL
Intervention: Abemaciclib (150 mg twice daily) + fulvestrant/NSAI
Number of subjects: 0
Study 33906086 — intervention group
Group type: EXPERIMENTAL
Intervention: Abemaciclib
Number of subjects: 0
Study 34240656 — intervention group
Group type: EXPERIMENTAL
Intervention: Temelimab 18 mg/kg
Number of subjects: 270
Study 34240656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study 34887867 — intervention group
Group type: EXPERIMENTAL
Intervention: AZ vaccination
Number of subjects: 80
Study 34887867 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA vaccination
Number of subjects: 80
Study 33559090 — intervention group
Group type: EXPERIMENTAL
Intervention: AEA group (antofloxacin 200 mg once daily, esomeprazole 20 mg + amoxicillin 1000 mg twice daily for 14 days)
Number of subjects: 196
Study 32690743 — intervention group
Group type: EXPERIMENTAL
Intervention: Wool-derived keratin dressing
Number of subjects: 143
Study 32690743 — intervention group
Group type: COMPARATOR
Intervention: Usual care dressings
Number of subjects: 143
Study 35637753 — intervention group
Group type: EXPERIMENTAL
Intervention: Platform-switched (PS) abutments
Number of subjects: 27
Study 35637753 — intervention group
Group type: COMPARATOR
Intervention: Nonplatform-switched (NPS) abutments
Number of subjects: 27
Study 34029860 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 41
Study 34029860 — intervention group
Group type: COMPARATOR
Intervention: Face-to-Face (F2F)
Number of subjects: 41
Study 34984845 — intervention group
Group type: EXPERIMENTAL
Intervention: Normoxia
Number of subjects: 8
Study 34984845 — intervention group
Group type: COMPARATOR
Intervention: Hypoxia (12% O2)
Number of subjects: 8
Study 34628742 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture and medication group 1 (2 Hz continuous wave)
Number of subjects: 118
Study 34628742 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture and medication group 2 (50 Hz continuous wave)
Number of subjects: 118
Study 34628742 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture and medication group 3 (2 Hz/50 Hz disperse-dense wave)
Number of subjects: 118
Study 34628742 — intervention group
Group type: COMPARATOR
Intervention: Medication group (conventional medication)
Number of subjects: 118
Study 33093030 — intervention group
Group type: EXPERIMENTAL
Intervention: 4CMenB vaccination
Number of subjects: 24000
Study 33093030 — intervention group
Group type: EXPERIMENTAL
Intervention: MenB-fHbp vaccination
Number of subjects: 24000
Study 33093030 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vaccination initially)
Number of subjects: 24000
Study 33093030 — intervention group
Group type: EXPERIMENTAL
Intervention: 4CMenB vaccination (after 12 months for control group)
Number of subjects: 24000
Study 33093030 — intervention group
Group type: EXPERIMENTAL
Intervention: 4CMenB and MenB-fHbp vaccinations
Number of subjects: 24000
Study 36206044 — intervention group
Group type: EXPERIMENTAL
Intervention: SOVA intervention (peer support website)
Number of subjects: 146
Study 36206044 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 146
Study 32652065 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-unit protocol (1 unit of packed red blood cells)
Number of subjects: 66
Study 32652065 — intervention group
Group type: COMPARATOR
Intervention: Multiple-unit protocol (2 units of packed red blood cells)
Number of subjects: 66
Study 34414814 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint mobilization and therapeutic exercises (physical therapy group)
Number of subjects: 24
Study 34414814 — intervention group
Group type: COMPARATOR
Intervention: Control group (booklet only)
Number of subjects: 24
Study 33992570 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT-D (Cardiac Resynchronization Therapy with Defibrillator)
Number of subjects: 555
Study 33992570 — intervention group
Group type: COMPARATOR
Intervention: CRT-P (Cardiac Resynchronization Therapy without Defibrillator)
Number of subjects: 555
Study 33992570 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT-D
Number of subjects: 555
Study 33992570 — intervention group
Group type: COMPARATOR
Intervention: CRT-D and CRT-P
Number of subjects: 555
Study 32638392 — intervention group
Group type: EXPERIMENTAL
Intervention: Shaving
Number of subjects: 0
Study 32638392 — intervention group
Group type: EXPERIMENTAL
Intervention: Plucking
Number of subjects: 0
Study 32638392 — intervention group
Group type: EXPERIMENTAL
Intervention: Waxing
Number of subjects: 0
Study 32638392 — intervention group
Group type: EXPERIMENTAL
Intervention: All techniques
Number of subjects: 0
Study 35550459 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraglottic airway device (SAD) general anesthesia
Number of subjects: 116
Study 35550459 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal intubation (EI) general anesthesia
Number of subjects: 116
Study 33862308 — intervention group
Group type: EXPERIMENTAL
Intervention: SBR boot condition
Number of subjects: 24
Study 33862308 — intervention group
Group type: COMPARATOR
Intervention: PU boot condition
Number of subjects: 24
Study 33862308 — intervention group
Group type: EXPERIMENTAL
Intervention: Loaded walking (15-kg backpack)
Number of subjects: 24
Study 33862308 — intervention group
Group type: COMPARATOR
Intervention: Loaded walking (no backpack)
Number of subjects: 24
Study 32896992 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose regimen of methotrexate (MTX)
Number of subjects: 89
Study 32896992 — intervention group
Group type: COMPARATOR
Intervention: Triple-dose regimen of methotrexate (MTX)
Number of subjects: 89
Study 35148577 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic duct ligation
Number of subjects: 69
Study 35148577 — intervention group
Group type: COMPARATOR
Intervention: Non-ligation (control group)
Number of subjects: 69
Study 36153501 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal protection package consisting of long-lasting insecticidal hammock net, insect repellent, and health communication pamphlet.
Number of subjects: 488
Study 36153501 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 488
Study 34708785 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone group (DEX)
Number of subjects: 151
Study 34708785 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) group
Number of subjects: 151
Study 32500733 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% dilution of lavender scent for 2 weeks
Number of subjects: 58
Study 32500733 — intervention group
Group type: COMPARATOR
Intervention: Nonscent for 2 weeks
Number of subjects: 58
Study 35263547 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-based sanitiser (AS)
Number of subjects: 0
Study 35263547 — intervention group
Group type: EXPERIMENTAL
Intervention: Capric acid-based sanitiser (CS)
Number of subjects: 0
Study 35263547 — intervention group
Group type: EXPERIMENTAL
Intervention: Any hand sanitiser
Number of subjects: 0
Study 35263547 — intervention group
Group type: COMPARATOR
Intervention: Neutralisers in agar
Number of subjects: 0
Study 33574371 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate juice (8 oz daily)
Number of subjects: 99
Study 33574371 — intervention group
Group type: COMPARATOR
Intervention: Placebo juice
Number of subjects: 99
Study 32971350 — intervention group
Group type: EXPERIMENTAL
Intervention: Active monitoring for low-risk DCIS
Number of subjects: 26
Study 32971350 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 26
Study 35144303 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral triangle block (FTB) and interspace between the popliteal artery and the capsule of the posterior knee (IPACK)
Number of subjects: 40
Study 35144303 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular cocktail analgesic mixture local injection
Number of subjects: 40
Study 34635855 — intervention group
Group type: EXPERIMENTAL
Intervention: PF‐05221304 2 mg QD
Number of subjects: 305
Study 34635855 — intervention group
Group type: EXPERIMENTAL
Intervention: PF‐05221304 10 mg QD
Number of subjects: 305
Study 34635855 — intervention group
Group type: EXPERIMENTAL
Intervention: PF‐05221304 25 mg QD
Number of subjects: 305
Study 34635855 — intervention group
Group type: EXPERIMENTAL
Intervention: PF‐05221304 50 mg QD
Number of subjects: 305
Study 34635855 — intervention group
Group type: EXPERIMENTAL
Intervention: PF‐05221304 (15 mg BID) + PF‐06865571 (300 mg BID)
Number of subjects: 305
Study 34635855 — intervention group
Group type: EXPERIMENTAL
Intervention: PF‐05221304 alone
Number of subjects: 305
Study 34635855 — intervention group
Group type: EXPERIMENTAL
Intervention: PF‐06865571 alone
Number of subjects: 305
Study 34635855 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 305
Study 34635855 — intervention group
Group type: EXPERIMENTAL
Intervention: PF‐05221304 (any dose)
Number of subjects: 305
Study 34635855 — intervention group
Group type: EXPERIMENTAL
Intervention: PF‐05221304 + PF‐06865571
Number of subjects: 305
Study 32990311 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy visits (number and timing)
Number of subjects: 326
Study 32675019 — intervention group
Group type: EXPERIMENTAL
Intervention: 52 mL/day EVOO
Number of subjects: 129
Study 32675019 — intervention group
Group type: EXPERIMENTAL
Intervention: DieTBra
Number of subjects: 129
Study 32675019 — intervention group
Group type: EXPERIMENTAL
Intervention: DieTBra + 52 mL/day EVOO
Number of subjects: 129
Study 35780807 — intervention group
Group type: EXPERIMENTAL
Intervention: Odevixibat 40 μg/kg per day
Number of subjects: 62
Study 35780807 — intervention group
Group type: EXPERIMENTAL
Intervention: Odevixibat 120 μg/kg per day
Number of subjects: 62
Study 35780807 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined odevixibat group (40 μg/kg and 120 μg/kg)
Number of subjects: 62
Study 35780807 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 32894637 — intervention group
Group type: EXPERIMENTAL
Intervention: Early combination therapy (metformin plus vildagliptin)
Number of subjects: 186
Study 32894637 — intervention group
Group type: COMPARATOR
Intervention: Metformin monotherapy
Number of subjects: 186
Study 32416495 — intervention group
Group type: EXPERIMENTAL
Intervention: Future Specificity Training (FeST)
Number of subjects: 60
Study 32416495 — intervention group
Group type: COMPARATOR
Intervention: Wait-list
Number of subjects: 60
Study 36460003 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable‐resistance complex training (VRCT)
Number of subjects: 24
Study 36460003 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional complex training (TCT)
Number of subjects: 24
Study 36460003 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study 33580585 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural lung recruitment maneuver
Number of subjects: 84